FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 88 filers reported holding FORTRESS BIOTECH INC in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | -72.2% | 2,072 | -80.3% | 0.00% | – |
| Q4 2020 | $36,000 | +200.0% | 10,516 | +260.8% | 0.00% | – |
| Q3 2020 | $12,000 | -14.3% | 2,915 | -38.3% | 0.00% | – |
| Q2 2020 | $14,000 | – | 4,727 | +1600.4% | 0.00% | – |
| Q2 2019 | $0 | – | 278 | +195.7% | 0.00% | – |
| Q1 2019 | $0 | – | 94 | -82.1% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 524 | -44.6% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 945 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 945 | +34.6% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 702 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |